Adult-onset refractory inflammatory arthritis associated with somatic mosaicism of a truncating COPA mutation

Roads and detours for CAR T cell therapy in autoimmune diseases

Mucosal-Associated Invariant T Cells in Rheumatic Diseases

Hand function impairment in Systemic Sclerosis: determinants through investigations of clinical, radiographic and ultrasonographic features

18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica

[Care pathway to diagnosis in fibromyalgia and inflammatory rheumatic diseases: A patient-centered approach using a comparative mixed-methods study]

Teleconsultation for rheumatoid arthritis: A selective therapeutic tool in routine care

Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease

CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms

Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practice

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective

Inflammatory and angiogenic serum profile of refractory rheumatoid arthritis

CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?

Short telomere length is associated with accelerated lung disease progression in rheumatoid arthritis-associated interstitial lung disease

Response to the letter to the editor entitled "Is there room for precocious prevention in rheumatoid arthritis precision medicine?"

French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases

Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges

Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis: reply

Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis

CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis

Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

DAS28-γGT for the prediction of major cardiovascular events in rheumatoid arthritis: results from the ESPOIR cohort

Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease

Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide

2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

Granulocytes and monocytes apheresis for polyarthritis in a multimorbid patient

Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation

Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study

Successful treatment of multicentric reticulohistiocytosis with JAK inhibitor: a case series

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry

Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study

Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study

Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study

Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial

Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?

Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations

Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

The Cardiovascular Safety of Tumour Necrosis Factor Inhibitors in Arthritic Conditions: A Structured Review with Recommendations

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study

Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis

Clinical and pharmacological outcomes after switching from intravenous to subcutaneous infliximab in chronic inflammatory rheumatic diseases

Intestinal barrier biomarkers in adult patients with juvenile idiopathic arthritis in transition

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Nailfold videocapillaroscopy findings and associations with organ involvement in mixed connective tissue disease

Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary

Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis